Literature DB >> 26045512

Secondary forms of Takotsubo cardiomyopathy: A whole different prognosis.

Iván J Núñez-Gil1, Manuel Almendro-Delia2, Mireia Andrés3, Alessandro Sionis4, Ana Martin5, Teresa Bastante6, Juan G Córdoba-Soriano7, José A Linares8, Silvia González Sucarrats9, Alejandro Sánchez-Grande-Flecha10, Oscar Fabregat-Andrés11, Beatriz Pérez12, Juan M Escudier-Villa13, Roberto Martin-Reyes14, Alberto Pérez-Castellanos15, Ferrán Rueda Sobella16, Cristina Cambeiro17, Jesús Piqueras-Flores18, Rafael Vidal-Perez19, Vicente Bodí20, Bernardo García de la Villa21, Miguel Corbí-Pascua17, Corina Biagioni22, Hernán D Mejía-Rentería22, Gisela Feltes22, José Barrabés3.   

Abstract

BACKGROUND: Takotsubo syndrome (TKS) usually mimics an acute coronary syndrome. However, several clinical forms have been reported. Our aim was to assess if different stressful triggers had prognostic influence on TKS, and to establish a working classification.
METHODS: We performed an analysis including patients with TKS between 2003-2013 from our prospective local database and the RETAKO National Registry, fulfilling Mayo criteria. Patients were divided in two groups regarding their potential triggers: (a) none/psychic stress as 'primary forms' and (b) physical factors (asthma, surgery, trauma, etc.) as 'secondary forms'.
RESULTS: Finally, 328 patients were included, 90.2% women, with a mean age of 69.7 years. Patients were divided into primary TKS (n=265) and 63 secondary TKS groups. Age, gender, previous functional class and cardiovascular risk profile displayed no differences between groups before admission. However, primary-TKS patients suffered a main complaint of chest pain (89.4% vs 50.7%, p<0.0001) with frequent vegetative symptoms. Regarding treatment before admission, there were no differences either. During admission, differences were related to more intensive antithrombotic and anxiolytic drug use in the primary TKS group. Inotropic and mechanical ventilation use was higher in the secondary cohort. After discharge, a more frequent prescription of beta-blockers and statins in primary-TKS patients was seen. Secondary forms displayed more in-hospital stay and evolutive complications: death (hazard ratio (HR): 3.41; 95% confidence interval (CI): 1.14-10.16, p=0.02), combined event variable (MACE) (HR: 1.61; 95% CI: 1.01-2.6, p=0.04) and recurrences (HR: 1.85; 95% CI: 1.06-3.22, p=0.02).
CONCLUSION: Secondary TKS could present or mark worse short and long-term prognoses in terms of mortality, recurrences and readmissions. We propose a simple working nomenclature for TKS. © The European Society of Cardiology 2015.

Entities:  

Keywords:  RETAKO; Takotsubo syndrome; classification; nomenclature; prognosis; secondary

Mesh:

Year:  2015        PMID: 26045512     DOI: 10.1177/2048872615589512

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN: 2048-8726


  17 in total

1.  Mortality in Takotsubo cardiomyopathy should also be accounted based on predisposing etiology.

Authors:  Lovely Chhabra; Pooja Sareen; Victor Mwansa; Nauman Khalid
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-06-02       Impact factor: 1.468

2.  Response to letter of the editor "Mortality in Takotsubo Cardiomyopathy should also be accounted based on predisposing etiology".

Authors:  Narut Prasitlumkum; Pattara Rattanawong
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-06-02       Impact factor: 1.468

3.  Hospital readmission following takotsubo syndrome.

Authors:  Nathaniel R Smilowitz; Anais Hausvater; Harmony R Reynolds
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2019-04-01

4.  Prognostic value of N-Terminal Pro-B-Type Natriuretic Peptide in Takotsubo syndrome.

Authors:  Thomas Stiermaier; Francesco Santoro; Tobias Graf; Francesca Guastafierro; Nicola Tarantino; Luisa De Gennaro; Pasquale Caldarola; Matteo Di Biase; Holger Thiele; Natale D Brunetti; Christian Möller; Ingo Eitel
Journal:  Clin Res Cardiol       Date:  2018-04-19       Impact factor: 5.460

5.  "Lambda-wave" ST-elevation is associated with severe prognosis in stress (takotsubo) cardiomyopathy.

Authors:  Nicola Tarantino; Francesco Santoro; Francesca Guastafierro; Luigi F M Di Martino; Maria Scarcia; Riccardo Ieva; Antonio Ruggiero; Andrea Cuculo; Enrica Mariano; Matteo Di Biase; Natale Daniele Brunetti
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-07-09       Impact factor: 1.468

Review 6.  Assessing the Role of High-Dose β-Agonists Use in Triggering Takotsubo Syndrome During Asthma Exacerbation.

Authors:  Danish Abbasi; Saif Faiek; Waqas J Siddiqui; Angel Lopez-Candales
Journal:  Perm J       Date:  2022-04-05

7.  Etiologies, predictors, and economic impact of readmission within 1 month among patients with takotsubo cardiomyopathy.

Authors:  Mahek Shah; Pradhum Ram; Kevin Bryan U Lo; Natee Sirinvaravong; Brijesh Patel; Byomesh Tripathi; Shantanu Patil; Vincent M Figueredo
Journal:  Clin Cardiol       Date:  2018-07-20       Impact factor: 2.882

8.  Postoperative cardiogenic shock secondary to Takotsubo's syndrome.

Authors:  Tessa Dessain; Rachel Stewart; Shashank Patil
Journal:  BMJ Case Rep       Date:  2019-12-31

9.  Gender Differences in Clinical Profiles of Stress-Induced Cardiomyopathy.

Authors:  Hyung Yoon Kim; Joon-Hyung Doh; Shin Yi Jang; Eun Kyoung Kim; Joo-Yong Hahn; Duk-Kyung Kim
Journal:  J Cardiovasc Ultrasound       Date:  2017-12-29

Review 10.  Stress cardiomyopathy of the critically ill: Spectrum of secondary, global, probable and subclinical forms.

Authors:  Anand Chockalingam
Journal:  Indian Heart J       Date:  2017-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.